NYSE$ALUR
Allurion Technologies Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
Reported strong sequential revenue growth and record procedure volume.
Allurion Technologies, Inc. announced its Q2 2024 financial results, highlighted by a sequential revenue increase of $2.4 million from Q1 2024, reaching $11.8 million, and a 12% year-over-year growth in procedure volume. The company's loss from operations decreased by 30% compared to the previous year, and they updated their full-year 2024 revenue guidance to between $40 million and $45 million.
- Second quarter revenue reached $11.8 million, a sequential increase of $2.4 million or 25% from the first quarter of 2024.
- Second quarter loss from operations reduced by 30% compared to the year-ago period and by 44% when one-time financing costs are excluded.
- Procedure volume grew by 12% year-over-year, a quarterly record that equated to over 10,000 Allurion balloon placements for the second consecutive quarter.
- Full-year 2024 revenue guidance updated to between $40 million and $45 million.
Headline financials
Revenue & EPS history
Allurion · Revenue · Quarterly
$11.8M
Forward guidance
Allurion is updating its full-year 2024 revenue guidance to between $40 million and $45 million and expects growth in procedure volume to be between 10% and 15%.
Headwinds
- Disruption of sales in France due to regulatory suspension.
- More conservative assumptions on inventory stocking.
- Macroeconomic headwinds in other regions.
- Slower growth expected in the second half of 2024.
- Reductions in sales to certain accounts to manage credit risk.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2024
+1.5%
Avg return
Earnings day
+0.8%
Avg return
5 days after
+63.8%
Avg return
30 days after
48%
10 / 21 earnings
Positive
+47.1%
Q4 2025
Best reaction
-43.7%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +25.0% | +25.1% | +1467.3% | |
| Q4 2025 | +47.1% | +35.3% | +47.1% | |
| Q3 2025 | +1.4% | -6.0% | +12.1% | |
| Q2 2025 | +0.8% | -8.1% | -16.3% | |
| Q1 2025 | +25.1% | +29.7% | +5.1% | |
| Q4 2024 | +0.3% | +3.2% | -22.8% | |
| Q3 2024 | -43.7% | -46.2% | -51.3% | |
| Q2 2024 | -12.7% | -17.0% | -20.8% | |
| Q1 2024 | -1.0% | -8.8% | -28.4% | |
| Q4 2023 | -11.9% | -11.0% | -5.2% | |
| Q3 2022 | +2.4% | +0.7% | -18.7% | |
| Q3 2023 | +6.7% | +2.4% | -15.9% | |
| Q2 2022 | -2.3% | +3.8% | -3.6% | |
| Q1 2023 | -2.3% | +3.8% | -3.6% | |
| Q2 2023 | -2.3% | +3.8% | -3.6% | |
| Q4 2022 | -2.3% | +3.8% | -3.6% | |
| Q1 2022 | +0.0% | +0.2% | +0.3% | |
| Q4 2021 | +0.1% | +0.3% | -0.1% | |
| Q3 2021 | -0.2% | +0.0% | +0.0% | |
| Q2 2021 | -0.1% | -0.5% | -1.3% | |
| Q1 2021 | +0.9% | +1.0% | +2.4% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro